bias_variance
TL4 Biostatistician · Aarhus, DK
Biostatistician. I am the person who asks what the estimand was. Sorry in advance.
Joined 12 May 2024 · last posted 2h · groups: journal-club, trust-level-4
225 posts, newest first. Showing up to 150.
-
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #54 · Compounds › Secretagogues & GH axis · 28 Jul 2026 · 4 likes Development history is more informative than speculation: ipamorelin was investigated clinically for post-operative ileus and was not taken forward to registration.…
-
What to bring: records that a clinician can actually use — a second dataset Replied, post #83 · Clinical › Prescriber conversations · 27 Jul 2026 · 30 likes Clarifying indication: if a compound is approved for diabetes but you have obesity without diabetes, clarify whether your clinician considers this off-label use and…
-
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #73 · Analytics › HPLC & UHPLC · 26 Jul 2026 · 0 likes Peak purity: a diode-array detector records a spectrum at every time point. If a peak contains two co-eluting species with different spectra, the spectrum changes…
-
Common supplements people ask about, assessed one at a time Replied, post #87 · Practice › Interactions · 23 Jul 2026 · 2 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
PIONEER 6 cardiovascular safety, read as a safety trial rather than an efficacy one Replied, post #18 · Compounds › Oral incretins · 23 Jul 2026 · 4 likes Worth separating two things that post #14 runs together. Fasting instructions are not optional advice. Taking the tablet with food or with more than a sip of water…
-
Seven-day rolling means and why weekly readings mislead Replied, post #65 · Outcomes › Progress reports · 20 Jul 2026 · 28 likes Worth separating two things that post #61 runs together. Exercise volume changes: increasing exercise intensity or duration can mask weight loss (muscle gain) on the…
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #65 · Compounds › Retatrutide · 15 Jul 2026 · 4 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Second pass at: When your prescriber and the evidence disagree Replied, post #50 · Clinical › Prescriber conversations · 14 Jul 2026 · 0 likes Questions about dose: asking "how will we determine whether this dose is working for me" gets at the monitoring plan. Asking "can we start lower" or "can we escalate…
-
Immortal time bias in a claims-database study — one year on Replied, post #23 · Evidence › Study critique · 14 Jul 2026 · 3 likes Defending a paper against criticism: if the authors respond, they might clarify something the paper explained poorly. Their response might also miss your point. Either…
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #77 · Analytics › Impurities & related substances · 14 Jul 2026 · 25 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Reading order for a first week here, and what to skip until later — what changed since Replied, post #42 · Start Here › Welcome · 14 Jul 2026 · 8 likes Picking up post #39: that is the part I would want checked first. Off-topic posts that do not belong here belong in the Lounge instead. You are not in trouble if a…
-
Submitting a sample: the process end to end Replied, post #77 · Sourcing › Independent verification · 12 Jul 2026 · 0 likes Worth separating two things that post #73 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
-
Coming back to: Batch date after test date, and other internal inconsistencies Replied, post #10 · Analytics › COA interpretation · 12 Jul 2026 · 3 likes Coming back to post #8, because the follow-up matters more than the original answer. A certificate of analysis is a statement by its issuer that a defined test was…
-
Packaging that arrived damaged: documenting it properly Replied, post #38 · Sourcing › Logistics · 7 Jul 2026 · 23 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
HbA1c lag and what it can and cannot tell you at eight weeks — one year on Replied, post #17 · Clinical › Bloodwork · 7 Jul 2026 · 31 likes On post #13 — agreed on the reasoning, with one qualification. Biological variation: the person-to-person variation in a biomarker for a healthy person is larger than…
-
Heart failure with preserved ejection fraction: symptom endpoints Replied, post #17 · Clinical › Comorbidities · 7 Jul 2026 · 31 likes post #16 answers the question as asked. The question underneath it is different. PCOS and metabolic overlap: polycystic ovary syndrome has metabolic overlap with…
-
Personal or family history of medullary thyroid carcinoma Replied, post #31 · Safety › Contraindications · 30 Jun 2026 · 21 likes Gastroparesis or severe delayed gastric emptying: these compounds slow gastric emptying. Pre-existing severe gastroparesis can be worsened. That is a relative…
-
Reading a rodent study on a secretagogue without over-extrapolating — the long version Replied, post #15 · Compounds › Secretagogues & GH axis · 29 Jun 2026 · 22 likes CJC-1295 with and without DAC: the version with a drug affinity complex binds albumin covalently and persists for days. The version without it does not persist.…
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #33 · Analytics › Impurities & related substances · 29 Jun 2026 · 32 likes Dimer and higher-order multimers: two or more peptide molecules bonded together. They appear at double the mass and higher. They may or may not separate from the…
-
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #50 · Compounds › Repair & healing peptides · 28 Jun 2026 · 7 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Pages past their review date, listed — does this still hold? Replied, post #28 · Meta › Wiki maintenance · 27 Jun 2026 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #39 · Access › International · 27 Jun 2026 · 0 likes Compounding in different countries: some countries allow pharmacy compounding under defined conditions; others do not. The rules are jurisdiction-specific and change.
-
Why a pen's dose steps are fixed and what that costs you Replied, post #2 · marked as the solution · Devices › Pens & autoinjectors · 24 Jun 2026 · 25 likes Pen confusion between compounds: if you are using multiple pens or alternating pens, confirming you have the correct pen before injection prevents administration…
-
Coming back to: A structured critique template this community uses Replied, post #37 · Evidence › Study critique · 19 Jun 2026 · 4 likes I read post #35 twice before replying, because I had assumed the opposite. When you change your mind: if a reply convinces you that your criticism was not well-founded,…
-
Splitting an overlong document into two Replied, post #26 · Documentation › Wiki requests · 17 Jun 2026 · 0 likes I read post #24 twice before replying, because I had assumed the opposite. Suggesting content for a page: if you know a maintained page is missing something important,…
-
Molecular mass of semaglutide and why the figure differs between sources Replied, post #78 · Compounds › Semaglutide · 14 Jun 2026 · 3 likes Coming back to post #76, because the follow-up matters more than the original answer. The mass figure differs between sources because of how the different entities…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #128 · Practice › Storage & stability · 10 Jun 2026 · 0 likes post #127 answers the question as asked. The question underneath it is different. Dating prepared solutions: write the date reconstitution on the vial in permanent…
-
Second pass at: Absence of evidence and evidence of absence Replied, post #17 · Research Methods › Statistics · 7 Jun 2026 · 29 likes Relative risk and odds ratios: both compare the rate in one group to the rate in another. Relative risk is easier to understand. Odds ratios are standard in many…
-
Reading a trial's population section before its results Replied, post #89 · Evidence › Trials · 5 Jun 2026 · 27 likes Picking up post #86: that is the part I would want checked first. Dropout is information: high dropout rates can indicate tolerability problems or lower efficacy than…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #89 · Sourcing › Logistics · 2 Jun 2026 · 7 likes Customs outcomes are not predictable at the level of an individual parcel. What is predictable is that consistent, accurate declarations correlate with fewer…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #82 · Practice › Reconstitution · 31 May 2026 · 0 likes How much of the diluent volume the powder itself displaces: for a small peptide vial, the powder volume is negligible. For a larger vial or a kit with multiple…
-
Does dual agonism explain the effect size, or is it dose? Replied, post #8 · Compounds › Tirzepatide · 30 May 2026 · 0 likes SURMOUNT-1 reported weight reduction of a magnitude that was the largest for a pharmacological intervention at that time of publication. It also reported a clear dose…
-
Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #14 · Compounds › Semaglutide · 28 May 2026 · 2 likes On post #10 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
What to include when your question involves a chromatogram — one year on Replied, post #17 · Start Here › How to Ask · 27 May 2026 · 6 likes Five questions in one post gets you one answer: the easiest one, usually not the one you needed most. Post them separately or pick the one that depends on the others…
-
The anatomy of a question that gets answered within an hour Replied, post #57 · Start Here › How to Ask · 26 May 2026 · 26 likes Five questions in one post gets you one answer: the easiest one, usually not the one you needed most. Post them separately or pick the one that depends on the others…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #67 · Practice › Reconstitution · 23 May 2026 · 13 likes Over-dilution: if your target dose is 0.25 mg and your syringe is a 1 mL insulin syringe, you need a concentration high enough that 0.25 mg fits on the scale. A 0.25…
-
Two scans six weeks apart on different machines: a cautionary tale Replied, post #22 · Outcomes › Body composition · 20 May 2026 · 0 likes Ultrasound: thickness of subcutaneous fat at specific sites. Less standardised than DXA and operator-dependent. Useful as a supplementary measure but not as a primary…
-
Transporting a vial for a weekend away — a second dataset Replied, post #55 · Practice › Storage & stability · 17 May 2026 · 2 likes Refrigeration slows degradation. Repeated warming and cooling is worse than continuous refrigeration. Light exposure is worth avoiding. The concentration matters…
-
A checklist for reading a certificate in under two minutes Replied, post #22 · Analytics › COA interpretation · 16 May 2026 · 6 likes Purity and content are different measurements: purity tells you what proportion of the detected material is the intended species. Content tells you how much of the…
-
Reading a trial's population section before its results Replied, post #10 · Evidence › Trials · 10 May 2026 · 28 likes Surrogate endpoints: an endpoint that is not the outcome that matters but is measured as a stand-in. HbA1c is a surrogate for long-term glucose control and the…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #33 · Compounds › Tirzepatide · 8 May 2026 · 1 like post #32 answers the question as asked. The question underneath it is different. SURMOUNT-OSA is notable because it used an objective physiological endpoint, the…
-
How shortages have affected compounding permissions — does this still hold? Started this topic · Access › Shortages · 6 May 2026 · 3 likes How shortages have affected compounding permissions — does this still hold? — that is the question, and I have not found it answered plainly anywhere I have looked. A…
-
About the Insurance & coverage category Replied, post #6 · Access › Insurance & coverage · 5 May 2026 · 5 likes post #5 answers the question as asked. The question underneath it is different. Out-of-pocket costs: if insurance is not covering it, asking about patient assistance…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — a second dataset Replied, post #43 · Sourcing › Independent verification · 2 May 2026 · 10 likes Worth separating two things that post #39 runs together. Interpreting a result: a purity figure is one measurement on one vial on one day. Agreement across two services…
-
Anaesthesia and elective surgery: the aspiration question Replied, post #106 · Practice › Interactions · 30 Apr 2026 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Molecular mass of semaglutide and why the figure differs between sources Replied, post #45 · Compounds › Semaglutide · 28 Apr 2026 · 8 likes Worth separating two things that post #41 runs together. The 165 to 184 hour range: that is roughly 7 to 7.6 days, which is why the weekly schedule works. Below 4…
-
Two scans six weeks apart on different machines: a cautionary tale Replied, post #7 · marked as the solution · Outcomes › Body composition · 27 Apr 2026 · 7 likes Bioelectric impedance analysis: less precise than DXA and strongly affected by hydration state. Not reliable for detecting month-to-month changes. Useful for trend over…
-
About the Interactions category Replied, post #6 · Practice › Interactions · 22 Apr 2026 · 18 likes Supplements and herbs: many have no established interaction. Some do. If you are taking something unusual, checking a reference (like a pharmacist) is more useful than…
-
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #80 · Analytics › Mass spectrometry · 14 Apr 2026 · 19 likes Tandem mass spectrometry: MS/MS fragments the molecular ion and uses fragment masses to confirm identity and detect modifications. A simple identity confirmation by…
-
Racemisation and why it is invisible to a mass measurement — what changed since Replied, post #2 · Analytics › Impurities & related substances · 13 Apr 2026 · 17 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #105 · Clinical › Special populations · 10 Apr 2026 · 7 likes Hypoglycemia risk: in people already on insulin or sulfonylureas, adding a GLP-1 agonist requires insulin dose reduction and close monitoring for hypoglycemia. This is…
-
Spike-and-recover accuracy for a peptide assay Replied, post #31 · Analytics › Method validation · 7 Apr 2026 · 15 likes On post #27 — agreed on the reasoning, with one qualification. Precision and repeatability: within-run and between-run variability of the method. Acceptance criterion…
-
Follow-up: State-level differences that actually matter Replied, post #48 · Regional › North America · 6 Apr 2026 · 0 likes Picking up post #45: that is the part I would want checked first. Cross-border purchase: buying in the US and bringing to Canada or vice versa involves both countries'…
-
Revisiting: Drawing up with one needle and injecting with another Replied, post #14 · Practice › Administration · 1 Apr 2026 · 5 likes Pinch or no pinch: the decision depends on needle length and on your own anatomy. A longer needle (8 mm and up) reaches subcutaneous tissue easily without a pinch. A…
-
The "under review" status pill and when a moderator applies it Replied, post #41 · Evidence › Preprints · 28 Mar 2026 · 17 likes post #40 answers the question as asked. The question underneath it is different. Do not build anything on a preprint that you would mind rebuilding: if the preprint…
-
The anatomy of a question that gets answered within an hour Replied, post #5 · Start Here › How to Ask · 26 Mar 2026 · 1 like Questions you cannot explain: "I cannot say why I am asking this, but is this compound stable at room temperature?" is more productive than no question at all. People…
-
Named, unnamed and unspecified impurities as regulatory categories Replied, post #10 · Analytics › Impurities & related substances · 21 Mar 2026 · 12 likes Coming back to post #8, because the follow-up matters more than the original answer. Acetate content: counter-ion content. Trifluoroacetate or acetate from the salt…
-
The "under review" status pill and when a moderator applies it Replied, post #16 · Evidence › Preprints · 11 Mar 2026 · 1 like Do not build anything on a preprint that you would mind rebuilding: if the preprint later changes substantially in revision or shows different results when published,…
-
A plateau that disappeared when I changed how I measured Replied, post #22 · Outcomes › Progress reports · 10 Mar 2026 · 24 likes Longitudinal report with the method stated: same scale, same time of day, same conditions. A scale is a tool; use the same one each time. Consistency matters more than…
-
The lowest dose that does anything: is that a real question? Replied, post #109 · Practice › Dosing & titration · 8 Mar 2026 · 4 likes Coming back to post #107, because the follow-up matters more than the original answer. Holding a dose indefinitely: the trials did not study indefinite holding at a…
-
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #5 · Evidence › Preprints · 3 Mar 2026 · 0 likes Always label it as a preprint in any discussion. A preprint is not a published trial and it is not settled knowledge. Use it for hypothesis generation and for…
-
[2026 update] What a purity-only report leaves out Replied, post #38 · Sourcing › Independent verification · 28 Feb 2026 · 27 likes Coming back to post #36, because the follow-up matters more than the original answer. PeptideMeter: purity analysis plus structured, dated supplier verification…
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #55 · Clinical › Special populations · 26 Feb 2026 · 0 likes Adolescents: a distinct evidence base exists. The compounds are not approved for routine adolescent obesity but are being studied. Adolescent physiology and psychology…
-
Non-inferiority margins: how they are chosen and how they are abused — a second dataset Replied, post #38 · Evidence › Trials · 25 Feb 2026 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #100 · Documentation › Wiki requests · 21 Feb 2026 · 10 likes Worth separating two things that post #96 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
-
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #12 · Compounds › Repair & healing peptides · 20 Feb 2026 · 0 likes For anyone arriving from search engines: this subcategory discusses published preclinical work and the absence of published clinical work. It does not endorse or…
-
Why one laboratory's 98.4% and another's 96.1% may not contradict — one year on Replied, post #9 · Analytics › Method validation · 20 Feb 2026 · 20 likes Accuracy: the method measures what you intend to measure. For purity methods, this is tested by spike-and-recover experiments: add a known amount of impurity to a…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #67 · Practice › Dosing & titration · 18 Feb 2026 · 4 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #38 · Practice › Dosing & titration · 17 Feb 2026 · 8 likes The arithmetic of an intermediate dose: if the label says 1.0 mg and 2.0 mg, a dose strictly between them is off-label by definition. Some people compute it anyway. The…
-
Amylin receptor signalling and satiety — what changed since Replied, post #31 · Pharmacology › Receptor biology · 16 Feb 2026 · 2 likes GLP-1 receptor signalling: the GLP-1 receptor is expressed on beta cells (insulin secretion), on neurons (appetite and gastric motility), and on myocardium…
-
[2026 update] Confounding by indication, explained with a concrete example Replied, post #56 · Evidence › Study critique · 15 Feb 2026 · 5 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Mass error in ppm: the arithmetic and the caveat Replied, post #106 · Analytics › Mass spectrometry · 15 Feb 2026 · 16 likes On post #102 — agreed on the reasoning, with one qualification. Resolution: "high resolution" commonly means
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #110 · Access › International · 15 Feb 2026 · 11 likes Regulatory position dates: a regulatory position is only current as of when it was written. Rechecking is prudent, especially if you saw it months ago.
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #50 · Practice › Interactions · 15 Feb 2026 · 0 likes Metformin: commonly co-administered and relevant to gastrointestinal tolerability. Gastrointestinal side effects can overlap and additive. Taking them separately or…
-
Travelling with an injectable: documentation and practicalities Replied, post #10 · Access › International · 11 Feb 2026 · 1 like Insurance and coverage: coverage decisions are national. A compound approved in one country might not be covered by insurance in another. Checking both approval and…
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #4 · Meta › Announcements · 10 Feb 2026 · 7 likes Worth separating two things that post #2 runs together. Staff-only posts: some announcements are visible only to staff (concerning internal operations). Members see…
-
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #65 · Compounds › Semaglutide · 9 Feb 2026 · 14 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #102 · Clinical › Special populations · 26 Jan 2026 · 18 likes Disordered eating history: a history of anorexia nervosa, bulimia, or other eating disorders changes the risk-benefit calculation because appetite suppression might…
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #85 · Clinical › Special populations · 25 Jan 2026 · 1 like Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Constipation management, with a dietitian's contribution Replied, post #21 · Practice › Side effects · 20 Jan 2026 · 5 likes This follows post #18 rather than contradicting it. Gallbladder complications: rapid weight loss increases the risk of gallstone formation. The mechanism is not…
-
Analytical identity of BPC-157: a 15-mer with a simple mass — does this still hold? Replied, post #5 · Compounds › Repair & healing peptides · 20 Jan 2026 · 5 likes post #4 answers the question as asked. The question underneath it is different. Oral versus injected administration claims for BPC-157: the preclinical work studied…
-
MHRA statements, read directly Replied, post #68 · Regional › UK & Ireland · 14 Jan 2026 · 0 likes NHS access has been restricted by commissioning criteria, not by licensing. Specialist weight-management services in many areas require prior weight-loss attempts, BMI…
-
Follow-up: Reconciling a label claim with a content assay Replied, post #2 · Analytics › COA interpretation · 10 Jan 2026 · 18 likes the opening post is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive…
-
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #48 · Clinical › Bloodwork · 10 Jan 2026 · 0 likes On post #44 — agreed on the reasoning, with one qualification. HbA1c and glucose: HbA1c reflects average glucose over months; a spot glucose measurement reflects the…
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #11 · Clinical › Special populations · 10 Jan 2026 · 0 likes Hepatic impairment: less is known about dosing in significant liver disease than in kidney disease. Extreme caution applies because the liver metabolises a large…
-
Personal import allowances, compared — a second dataset Replied, post #48 · Access › International · 7 Jan 2026 · 13 likes Picking up post #45: that is the part I would want checked first. Insurance and coverage: coverage decisions are national. A compound approved in one country might not…
-
Request: export my own posts — one year on Replied, post #30 · Meta › Feature requests · 4 Jan 2026 · 0 likes Tracking: staff will update the status of feature requests (under consideration, planned, implemented, declined). Checking back lets you know the fate of your suggestion.
-
A single out-of-range value on an otherwise normal panel Replied, post #2 · Clinical › Bloodwork · 30 Dec 2025 · 0 likes Worth separating two things that the opening post runs together. HbA1c and glucose: HbA1c reflects average glucose over months; a spot glucose measurement reflects the…
-
Vomiting: when it is expected and when it is a reason to stop Replied, post #116 · Practice › Side effects · 30 Dec 2025 · 9 likes Coming back to post #114, because the follow-up matters more than the original answer. Delayed gastric emptying: the mechanism behind much of the gastrointestinal…
-
Heterogeneity as information rather than as a nuisance Replied, post #22 · Evidence › Meta-analyses · 11 Dec 2025 · 0 likes I read post #20 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
-
Reused chromatograms across lots: how to spot it Replied, post #7 · Analytics › COA interpretation · 8 Dec 2025 · 0 likes Endotoxin testing is separate: a certificate of purity says nothing about endotoxin. A chemically pure preparation can carry a clinically significant endotoxin load. If…
-
A pen that felt like it delivered nothing: diagnosing it afterwards Replied, post #31 · Devices › Pens & autoinjectors · 5 Dec 2025 · 0 likes Coming back to post #29, because the follow-up matters more than the original answer. Priming: most pens require priming before the first use (injecting a small amount…
-
Can a home kit substitute for a laboratory report? A careful no Replied, post #68 · Analytics › Home & field testing · 2 Dec 2025 · 0 likes Precision of home tests: most consumer-accessible devices are not precise to the level people want ("is this 99% pure or 97% pure"). They give a yes/no or a rough…
-
What pooling buys you and what it destroys Replied, post #75 · Evidence › Meta-analyses · 25 Nov 2025 · 1 like Fixed-effects versus random-effects models: fixed-effects assumes all studies are estimating the same thing and variation is sampling error. Random-effects assumes…
-
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #69 · Compounds › Other compounds · 25 Nov 2025 · 0 likes This subcategory exists because some people will research compounds outside the main groups discussed here. The standard of evidence and honesty about its limits…
-
Coverage in the US: a map of the usual obstacles Replied, post #14 · Regional › North America · 23 Nov 2025 · 13 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
DXA precision and the least significant change for lean mass Replied, post #9 · Outcomes › Body composition · 20 Nov 2025 · 20 likes Maintenance phase: tracking body composition during maintenance (weight stable) is different from tracking during active loss. Changes are smaller and precision becomes…
-
[2026 update] What steady state means for the decision to escalate Replied, post #92 · Practice › Dosing & titration · 14 Nov 2025 · 17 likes Coming back to post #90, because the follow-up matters more than the original answer. When a dose reduction is the correct response to a side effect: if a side effect…
-
Pharmaceutical compounding rules, summarised from primary sources — a second dataset Replied, post #25 · Sourcing › Regulatory · 11 Nov 2025 · 6 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #52 · Start Here › How to Ask · 2 Nov 2025 · 2 likes Worth separating two things that post #48 runs together. Avoid "any advice?" at the end. It is so generic that people do not know which part of the post it refers to.…
-
Thyroid function tests during substantial weight change Replied, post #109 · Clinical › Bloodwork · 25 Oct 2025 · 3 likes Reference intervals: constructed to contain the central 95% of a reference population, which means one in twenty healthy people falls outside one by definition. Add…
-
Second pass at: The mass-error checker and its intended scope Replied, post #46 · Data & Tools › Calculators · 24 Oct 2025 · 5 likes On post #42 — agreed on the reasoning, with one qualification. Reporting bugs: if you notice a calculator giving wrong results, report it in this subcategory. Bugs are…
-
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #107 · Start Here › Welcome · 22 Oct 2025 · 1 like For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Sleep quality changes during weight loss — what changed since Replied, post #33 · Wellbeing › Sleep · 20 Oct 2025 · 0 likes post #32 answers the question as asked. The question underneath it is different. Sleep quality versus quantity: some people report changes to sleep duration; others…
-
What pooling buys you and what it destroys Replied, post #44 · Evidence › Meta-analyses · 17 Oct 2025 · 2 likes Funnel plots: a plot of study effect size versus sample size that helps detect publication bias. If small studies are missing on the negative side, the funnel is…
-
Revisiting: Gallbladder disease risk with rapid weight loss Started this topic · Clinical › Comorbidities · 9 Oct 2025 · 0 likes Revisiting: Gallbladder disease risk with rapid weight loss Writing it up because I had to work it out twice and would rather nobody else did. Asking about a population…
-
[2026 update] Does dual agonism explain the effect size, or is it dose? Replied, post #40 · Compounds › Tirzepatide · 9 Oct 2025 · 12 likes SURMOUNT-OSA is notable because it used an objective physiological endpoint, the apnoea-hypopnoea index, rather than a symptom scale. Two parallel trials, with and…
-
What pooling buys you and what it destroys Replied, post #35 · Evidence › Meta-analyses · 4 Oct 2025 · 2 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
What a purity-only report leaves out Replied, post #32 · Sourcing › Independent verification · 2 Oct 2025 · 0 likes How to submit a sample: contact the service directly. They will provide instructions on vial type, quantity, labelling, shipping. Following their instructions exactly…
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #40 · Analytics › COA interpretation · 23 Sep 2025 · 6 likes A certificate of analysis is a statement by its issuer that a defined test was performed on a defined lot and produced a defined result. That is all it is, and it is…
-
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #49 · Lounge › Off topic · 21 Sep 2025 · 27 likes Politics and public policy: healthcare policy that affects access to these compounds is relevant here. Partisan politics is not.
-
Substitution between formats during a shortage Replied, post #60 · Access › Shortages · 20 Sep 2025 · 6 likes post #59 answers the question as asked. The question underneath it is different. Compounding during shortages: some jurisdictions allow pharmacy compounding when a…
-
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #120 · Access › Insurance & coverage · 15 Sep 2025 · 20 likes Prior authorisation: pre-approval requirements and how to satisfy them. Most denials cite specific criteria. Understanding the criterion is the first step in satisfying…
-
A ten-fold dose error caught before injection Replied, post #98 · Devices › Syringes & needles · 11 Sep 2025 · 2 likes On post #94 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
Pinch or no pinch, and how needle length changes the answer Replied, post #56 · Practice › Administration · 11 Sep 2025 · 0 likes Air bubbles in a subcutaneous injection: the honest risk assessment is low. Tiny air bubbles in subcutaneous tissue do not behave like an air embolism in a blood…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #122 · Data & Tools › Datasets · 10 Sep 2025 · 1 like How to contribute: if you have longitudinal data you want to add, the format is simple: date, measurement, context. Contact the maintainer of the specific dataset.
-
Which panel is worth repeating and which is worth ignoring Replied, post #107 · Clinical › Bloodwork · 10 Sep 2025 · 0 likes Lipid panel interpretation: total, LDL, HDL, triglycerides all on one panel. Reading them together is more informative than reading one value in isolation. An elevated…
-
Can a home kit substitute for a laboratory report? A careful no Replied, post #9 · marked as the solution · Analytics › Home & field testing · 9 Sep 2025 · 7 likes Molecular tests: DNA or RNA tests are not applicable to peptides, which do not contain nucleic acids. Peptide-specific tests rely on protein recognition, not…
-
Pooling trials with different estimands — what changed since Replied, post #20 · Evidence › Meta-analyses · 3 Sep 2025 · 0 likes Subgroup analysis: sometimes a meta-analysis reports separate pooled estimates for different subgroups (e.g., by baseline body mass index or by trial duration). Be…
-
Journal club: STEP-HFpEF and symptom endpoints — a second dataset Replied, post #6 · Evidence › Journal club · 31 Aug 2025 · 21 likes STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent comparison. Mean weight reduction was substantially…
-
Tirzepatide molecular mass and the charge states you would expect on ESI Replied, post #29 · Compounds › Tirzepatide · 28 Aug 2025 · 0 likes Worth separating two things that post #25 runs together. The GIP component: GIP receptor agonism is thought to amplify the GLP-1 effect on satiety and energy…
-
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #53 · Evidence › Journal club · 28 Aug 2025 · 2 likes FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic kidney disease. Stopped early for efficacy. Component-by-component analysis is…
-
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #44 · Evidence › Journal club · 24 Aug 2025 · 33 likes Coming back to post #42, because the follow-up matters more than the original answer. Session format: read the paper before posting. The discussion is much better when…
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #11 · Practice › Side effects · 23 Aug 2025 · 10 likes Gallbladder complications: rapid weight loss increases the risk of gallstone formation. The mechanism is not specific to this drug class. The risk is greatest in the…
-
What this community means by "a source", in practical terms Replied, post #78 · Start Here › Welcome · 19 Aug 2025 · 1 like For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #45 · Practice › Reconstitution · 19 Aug 2025 · 11 likes A vial that will not fully dissolve: check in order: is the diluent genuinely room temperature (some preservatives crystallise in cold), is the vial being warmed gently…
-
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #40 · Analytics › HPLC & UHPLC · 18 Aug 2025 · 0 likes post #39 answers the question as asked. The question underneath it is different. Detection wavelength: 214 nm detects the peptide bond and is relatively insensitive to…
-
Why catalogue breadth is not evidence of anything — what changed since Replied, post #17 · Compounds › Other compounds · 11 Aug 2025 · 0 likes I read post #15 twice before replying, because I had assumed the opposite. Why catalogue breadth is not evidence of anything: a supplier listing 500 compounds does not…
-
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #15 · Evidence › Journal club · 11 Aug 2025 · 6 likes SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg dose is not the highest available, which is the central and…
-
A request that was declined, and the reasoning — a second dataset Replied, post #10 · Documentation › Wiki requests · 5 Aug 2025 · 2 likes post #9 is right about the mechanism and I think understates the practical bit. Authority and authorship: if you think a maintained page needs input from someone with…
-
How to research a compound with no human data without deceiving yourself Replied, post #89 · Compounds › Other compounds · 3 Aug 2025 · 18 likes AOD-9604 is a fragment of human growth hormone and has been discussed as a potential weight-loss agent based on theoretical mechanism. The fragment hypothesis — that…
-
When a preprint is the best available evidence and we say so Replied, post #18 · Evidence › Preprints · 2 Aug 2025 · 31 likes post #17 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Revisiting: List price versus negotiated price versus what you pay Replied, post #2 · Access › Pricing · 1 Aug 2025 · 7 likes Compute cost per delivered dose at your dose if you want a number you can act on. That requires knowing your dose, vial volume, and whether you are using a vial or a pen.
-
"Should I double up?" — answered once, at length, calmly Replied, post #8 · Practice › Administration · 23 Jul 2025 · 32 likes post #7 answers the question as asked. The question underneath it is different. Air bubbles in a subcutaneous injection: the honest risk assessment is low. Tiny air…
-
Canadian access and provincial variation — one year on Replied, post #9 · Regional › North America · 20 Jul 2025 · 0 likes On post #5 — agreed on the reasoning, with one qualification. Private insurance gaps: some people have private insurance but medication is not covered. Manufacturer…
-
Meeting a protein target on a suppressed appetite Replied, post #10 · Nutrition & Training › Protein & intake · 16 Jul 2025 · 0 likes Protein targets during weight loss: the standard recommendation is 1.6 to 2.2 grams per kilogram of body weight. Individual requirements vary but that range is a…
-
Coming back to: Oxidation and deamidation mass shifts, tabulated Replied, post #20 · Analytics › Mass spectrometry · 12 Jul 2025 · 25 likes Coming back to post #18, because the follow-up matters more than the original answer. What mass accuracy establishes: the measured mass is consistent with a specific…
-
Temperature loggers worth the money — the long version Replied, post #9 · Devices › Cold chain · 8 Jul 2025 · 6 likes This follows post #6 rather than contradicting it. Temperature excursions: brief excursions above 8 °C are tolerable for most compounds. Hours to a day at room…
-
Reconstituting a multi-strength kit without mixing yourself up Replied, post #94 · Practice › Reconstitution · 2 Jul 2025 · 16 likes A vial that will not fully dissolve: check in order: is the diluent genuinely room temperature (some preservatives crystallise in cold), is the vial being warmed gently…
-
Repeatability versus intermediate precision Replied, post #77 · Analytics › Method validation · 27 Jun 2025 · 14 likes Precision and repeatability: within-run and between-run variability of the method. Acceptance criterion is typically a relative standard deviation of ≤2% for area…
-
A ten-fold dose error caught before injection Replied, post #54 · Devices › Syringes & needles · 24 Jun 2025 · 6 likes On post #50 — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
-
Repeatability versus intermediate precision Replied, post #28 · Analytics › Method validation · 21 Jun 2025 · 9 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #57 · Compounds › Cagrilintide & amylin analogues · 18 Jun 2025 · 29 likes Worth separating two things that post #53 runs together. The CagriSema phase 2 paper: a fixed combination of the two components in one weekly injection. The trade-off…
-
Anxiety in the first weeks: drug, situation, or both — what changed since Started this topic · Wellbeing › Mental health · 16 Jun 2025 · 1 like Anxiety in the first weeks: drug, situation, or both — what changed since Writing it up because I had to work it out twice and would rather nobody else did. Asking…
-
Follow-up: Tracking intake honestly when appetite is absent Replied, post #99 · Nutrition & Training › Protein & intake · 15 Jun 2025 · 6 likes post #98 is right about the mechanism and I think understates the practical bit. Eating anything at all: on substantial appetite suppression, eating enough total…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #100 · Access › Insurance & coverage · 13 Jun 2025 · 2 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #107 · Compounds › Tirzepatide · 11 Jun 2025 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Reconstituting a multi-strength kit without mixing yourself up Replied, post #83 · Practice › Reconstitution · 9 Jun 2025 · 1 like Worth separating two things that post #79 runs together. Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) = 2.5 mg/mL. On a U-100 syringe…
-
Journal club: SURMOUNT-4 and continuation versus withdrawal — a second dataset Replied, post #47 · Evidence › Journal club · 8 Jun 2025 · 5 likes Session format: read the paper before posting. The discussion is much better when everyone has. Start with the estimand and population, then methods, then results, then…
-
Coming back to: Getting a referral rather than a refusal Replied, post #44 · Clinical › Prescriber conversations · 8 Jun 2025 · 0 likes I read post #42 twice before replying, because I had assumed the opposite. Preparing for an appointment: bring recent bloodwork, a list of current medications with…